Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Remimazolam vs Propofol in Laser Burn Cases [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing remimazolam to propofol for procedural sedation during laser treatment of burn scars and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)
  • Remimazolam (remimazolam)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Burn Scar, Hypertrophic Scarring | Phase 4 | Status: RECRUITING